The Roles of Integrins and MAPK Signaling Pathways in the Osteoinduction of Biphasic Calcium Phosphate
Chen Xuening,Chen Ying,Wang Jing,Zhu Xiangdong,Fan Yujiang,Zhang Xingdong
DOI: https://doi.org/10.3389/conf.fbioe.2016.01.02042
IF: 5.7
2016-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Event Abstract Back to Event The roles of integrins and MAPK signaling pathways in the osteoinduction of biphasic calcium phosphate Xuening Chen1*, Ying Chen1*, Jing Wang1, Xiangdong Zhu1*, Yujiang Fan1* and Xingdong Zhang1* 1 Sichuan University, National Engineering Research Center for Biomaterials, China Introduction: Biphasic calcium phosphate (BCP) ceramics have been widely used in the orthopedic regime, due to their potential osteoconductivity and osteoinductivity[1]. However, the underlying mechanisms have not been fully understood. Generally, cells adhere to substrate surface via the transmembrane proteins - integrins, which cluster together into focal contacts, and subsequently trigger the intracellular signaling pathways, as so-called “outside-in signaling”. Previous studies demonstrate that integrins and its down-stream mitogen-activated protein kinase (MAPK) signalings have play an important role in bone formation[2]. Thus, their effects in BCP-inducing osteogenesis were under investigation. Material and Methods: Rat mesenchymal stem cells (MSCs) were isolated from bone marrow of young SD rats. Then, isolated MSCs of the third passage were seeded in osteoinductive BCP discs (Φ14×2 mm) , and maintained with α-MEM medium (10% FBS) in a 5% CO2 incubator at 37°C. Cells cultured in 24-well plates were used as control. Gene expression of targeted integrin subunits (i.e., Intg α2, α3, α5 and αv) was measured using qRT-PCR at 1, 4 and 7 days. Moreover, MSCs seeded in BCP scaffolds were lysed with ice-cold RIPA lysis buffer, and then phosphorylation of two main MAPK kinases (ERK1/2 and p38) were examined via western blotting analysis. The specific inhibitors of MEK⁄ERK (PD98059) and p38 MAPK (SB203580) were also added into culture medium, and their effects on BCP-inducing MSCs differentiation were further investigated via qRT-PCR and ELISA. Results and Discussion: It is well known that material-mediated activation of integrins play an essential role in signal transduction to regulate cell proliferation and differentiation[3]. In this study, qRT-PCR results showed that BCP scaffolds significantly increased integrin α2 expression by eight and four-fold at day 1 and 4, and integrin α3 expression by four, two and three-fold at day 1, 4 and 7 relative to control groups, respectively. Consistent with the previous findings, integrin α2β1 was implicated in pro-osteogenic pathways to activate osteoblastic differentiation, and activation of integrin α3β1 promoted the formation of mineralized nodules[4]. In contrast, there was a significant lower expression of Integrin α5 and αv on BCP scaffolds than controls, demonstrating that integrin α5 might have little or even negative effects on the BCP-inducing osteoblastic differentiaiton. The differential integrin expression might be due to the material-mediated protein adsorption or the properties of material surface. Moreover, previous studies suggested that MAPK was a potential integrin-stimulated down-stream signaling pathway[5]. Here, western blotting results indicated that BCP scaffolds dramatically promoted phosphorylation of ERK1/2, but they exerted relatively lower effects on p38. The addition of MAPK inhibitors (PD98059 and SB203580) could significantly down-regulate gene expression of several bone specific markers, including Runx2/cbfa1, osterix, bone sialoprotein (BSP) and osteoclacin (OCN), and dramatically reduce the production of OCN protein by BMSCs seeded on BCP scaffolds. These results indicated that ERK and p38 MAPK signalings might play a vital role in transducing intracellular signals, and directing MSC differentiation into osteogenic lineage during BCP-inducing bone formation. Conclusion: This study demonstrated that BCP scaffolds induced early osteogenic differentiation of MSCs by specifically activating integrins, and subsequently triggering MAPK signaling cascades to promote the expression of osteogenic genes. It might help to disclose the underlying mechanism of BCP's osteoinduction, and provide a useful principle for designing inducing materials in orthopedic application. References:[1] Zhang X, Zou P, Wu C. A study of porous block HA ceramics and its osteogenesis. In: Ravaglioli AK, editor. Bioceram. Hum. Body. The Nether, Amsterdam: 1991, p. 692–703.[2] Wang W, Liu Q, Zhang Y, Zhao L. Involvement of ILK/ERK1/2 and ILK/p38 pathways in mediating the enhanced osteoblast differentiation by micro/nanotopography. Acta Biomater 2014;10:3705–15.[3] Chen X, Fu X, Shi J, Wang H. Regulation of the osteogenesis of pre-osteoblasts by spatial arrangement of electrospun nanofibers in two- and three-dimensional environments. Nanomedicine 2013;9(8):1283-92.[4] Gronthos S, Stewart K, Graves S, Hay S, Simmons P. Integrin expression and function on human osteoblast-like cells. J Bone Min Res 1997;12:1189–97.[5] Lu Z, Zreiqat H. Beta-tricalcium phosphate exerts osteoconductivity through α2β1 integrin and down-stream MAPK/ERK signaling pathway. Biochem Biophys Res Commun 2010;394:323–9. Keywords: Mechanism, Calcium phosphate, Bone repair, matrix-cell interaction Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: General Session Oral Topic: Regenerative medicine: biomaterials for control of tissue induction Citation: Chen X, Chen Y, Wang J, Zhu X, Fan Y and Zhang X (2016). The roles of integrins and MAPK signaling pathways in the osteoinduction of biphasic calcium phosphate. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02042 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. * Correspondence: Dr. Xuening Chen, Sichuan University, National Engineering Research Center for Biomaterials, Chengdu, China, Email1 Dr. Ying Chen, Sichuan University, National Engineering Research Center for Biomaterials, Chengdu, China, Email2 Dr. Xiangdong Zhu, Sichuan University, National Engineering Research Center for Biomaterials, Chengdu, China, Email3 Dr. Yujiang Fan, Sichuan University, National Engineering Research Center for Biomaterials, Chengdu, China, Email4 Dr. Xingdong Zhang, Sichuan University, National Engineering Research Center for Biomaterials, Chengdu, China, Email5 Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Xuening Chen Ying Chen Jing Wang Xiangdong Zhu Yujiang Fan Xingdong Zhang Google Xuening Chen Ying Chen Jing Wang Xiangdong Zhu Yujiang Fan Xingdong Zhang Google Scholar Xuening Chen Ying Chen Jing Wang Xiangdong Zhu Yujiang Fan Xingdong Zhang PubMed Xuening Chen Ying Chen Jing Wang Xiangdong Zhu Yujiang Fan Xingdong Zhang Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.